Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 USD | +2.10% | +0.83% | -35.03% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.03% | 584M | B- | ||
+4.62% | 55.76B | A- | ||
-11.72% | 17.72B | A- | ||
-5.05% | 13.23B | A | ||
+1.40% | 7.68B | B | ||
-17.93% | 5.39B | B- | ||
+8.62% | 3.28B | C- | ||
-5.42% | 3.06B | B+ | ||
-8.15% | 2.73B | C | ||
+12.61% | 2.73B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DHC Stock
- Ratings Diversified Healthcare Trust